After Gujarat based pharmaceutical company Troika leveled allegation against Novartis that manufactures one of the most popular painkillers, diclofenac sodium, the drug regulator (Drug Controller General of India) has banned the drug and ordered the recall of the stock from the markets. Troika has alleged that diclofenac sodium 75mg/ml injection contains Transcutol-P which can cause renal damage. The injection was being marketed by Novartis under brand name Voveran. In Jammu and Kashmir not only banned drugs but spurious and substandard medicine has been found to be used in various government hospitals. After tests that were carried out earlier, 27 medicines were declared sub-standard and license of five firms were suspended. The menace of spurious drugs being sold over the counters and the supply reaching various state hospitals has not relieved the people even after the scandalous break of fake drugs years ago. Despite the assurance by government and state drug control authority that sub standard drugs would be eliminated from supply chains and comprehensive testing will be done in the state, the menace persists in the state. Not only the drug control or regulation system has become defunct, but the deterrent value has dropped to such a low that the unscrupulous elements are encouraged than discouraged to deal in low quality and dangerous drugs. The drug policy serves as a piece of paper that has gathered dust over the years instead of serving as guideline to regulate sale and use of drugs in the state. There are clear guidelines regarding the standard or quality of the drugs to be distributed/sold in the state, in spite of that sub standard drugs are still produced and merchandised. There are many banned drugs that are said to be sold at drug stores by the retailers. Rarely raids are conducted to check the stock of the drugs the retailers keep. It is likely that the banned drug Voveran will continue to be sold and used in the state despite it being banned, and such is the situation that exists in the state. In markets, drug regulation is more difficult than in hospitals as random samples can easily be picked from hospital stores, it is becoming more and more difficult in case of pharmacists and drug stores selling outside the hospitals. It is estimated that 80-90 percent of the drugs are circulated in the market and for which occasionally samples are lifted, meaning that margin for error is too great.